Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)
CUSIP: 08205P209
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 35,393,481
- Total 13F shares
- 21,243,183
- Share change
- +2,165,286
- Total reported value
- $277,395,506
- Price per share
- $13.01
- Number of holders
- 37
- Value change
- +$28,289,371
- Number of buys
- 25
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 08205P209?
CUSIP 08205P209 identifies BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 08205P209:
Top shareholders of BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
25%
|
8,960,009
|
$113,164,914 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
8.3%
|
2,939,287
|
$37,123,195 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
7.4%
|
2,616,427
|
$33,267,869 | — | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.6%
|
1,972,524
|
$24,912,978 | — | 31 Dec 2024 | |
| HBM Healthcare Investments (Cayman) Ltd. |
13D/G
|
— |
4.5%
|
1,041,669
|
$14,156,282 | $0 | 31 Dec 2024 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
4.4%
|
1,038,371
|
$14,111,462 | $0 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.85%
|
300,021
|
$3,789,265 | — | 31 Dec 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.74%
|
260,417
|
$3,289,066 | — | 31 Dec 2024 | |
| Steven Michael Oliveira |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,000,000
|
$3,044,300 | — | 28 Apr 2021 | |
| INFINITUM ASSET MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
210,000
|
$2,652,300 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
197,096
|
$2,489,808 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.49%
|
173,753
|
$2,194,500 | — | 31 Dec 2024 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.29%
|
102,027
|
$1,288,601 | — | 31 Dec 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.22%
|
76,337
|
$964,136 | — | 31 Dec 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
0.18%
|
62,000
|
$783,060 | — | 31 Dec 2024 | |
| MYDA Advisors LLC |
13F
|
Company |
0.14%
|
50,000
|
$631,500 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
42,367
|
$535,095 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
38,200
|
$482,466 | — | 31 Dec 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.1%
|
35,817
|
$452,369 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.1%
|
35,476
|
$448,062 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
24,772
|
$312,870 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.06%
|
20,896
|
$263,916 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
16,090
|
$203,217 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
12,463
|
$157,408 | — | 31 Dec 2024 | |
| GAMMA Investing LLC |
13F
|
Company |
0.02%
|
6,444
|
$81,388 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
5,013
|
$63,314 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,099
|
$13,880 | — | 31 Dec 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
671
|
$8,476 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
186
|
$2,349 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
173
|
$2,000 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
148
|
$1,869 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
89
|
$1,124 | — | 31 Dec 2024 |
Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) as of Q1 2025
As of 31 Mar 2025,
Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,243,183 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Nantahala Capital Management, LLC, INFINITUM ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, SILVERARC CAPITAL MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
30
Q1 2025 holders
37
Holder diff
7
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.